Our Science – Apolo Website
Andrea B. Apolo, M.D.
Dr. Apolo is dedicated to improving the treatment and survival of patients with genitourinary tumors. Her research involves developing and designing clinical trials to test novel agents for the treatment of urologic cancers. Her primary research interest is in bladder cancer (urothelial carcinoma) and prostate cancer. In particular, she is working to develop new bladder cancer therapies that use targeted agents including anti-angiogenesis compounds, which block the growth of new blood vessels that feed tumors. Other research focuses include improving tumor detection by using new imaging modalities in bladder and prostate cancer and identifying molecular alterations in bladder tumors that will serve as targets for individualized treatment strategies in patients with this disease.
Dr. Apolo is fluent in both English and Spanish.
Laura D. Otten, RN, BSN, OCN
(301) 451-1228 or toll-free 1-866-611-6310
This page was last updated on 7/23/2014.